63
Diamond Score
Guardian Pharmacy Services, Inc.
Healthcare · Medical - Distribution · $2.4B market cap
Overlooked
Strong Foundation
$37.79
Updated 2026-04-11
Discovery Thesis
AI-generated catalyst thesis will be available after transcript analysis. The quantitative signals below highlight why this company appears to be at an inflection point.
Quantitative summary: 3Q earnings beats, PEG 0.21.
Three-Pillar Score Breakdown
Valuation
✦ Reasonably Priced
GRDN trades at a PEG of 0.21 — paying less than half the typical price for its growth rate.
Inflection Signals
Revenue Acceleration
4Q data
QoQ growth: -0.0274 → 0.0456 → 0.0961 → 0.0535
Margin Expansion
2Q streak
Margins: 0.0395 → 0.0365 → 0.0433 → 0.1181
ROIC Trend
12.1%
0.0471 → 0.0402 → 0.0402 → 0.1206
Insider Buying
0 buys (90d)
PEG Ratio
0.21
Below 1.0 — undervalued relative to growth
Debt Paydown
D/E 0.217
0.182 → 0.235 → 0.185 → 0.217
Relative Strength (6M)
67.2%
Earnings Surprise Streak
2026-03-11
+37.0%
$0.37 vs $0.27
2025-11-10
+4.2%
$0.25 vs $0.24
2025-08-11
+4.5%
$0.23 vs $0.22
Foundation — Business Quality
Revenue Growth (YoY)
17.9%
Overlooked — Why the Market Hasn't Noticed
Analyst Coverage
2 analysts
Very low coverage
Market Cap
$2.4B
Sweet spot ($2-10B)
ETF Inclusion
Not in top ETFs